共 11 条
[1]
Extended spectrum beta-lactamase(ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Rupp M E,Fey P D. Drugs . 2003
[3]
Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. Lin M F,Huang M L,Lai S H. Journal of Hospital Infection . 2003
[4]
Antimicrobial resistance in Cairo, Egypt 1999 ~ 2000: a survey of five hospitals. El Kholy A,Baseem H,Hall G S,et al. Journal of Antimicrobial Chemotherapy . 2003
[5]
Extended-spectrum beta-lactamases: the European experience. Paterson D L. Current Opinion Infectious Diseases . 2001
[6]
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Kim Y K,Pai H,Lee H J,et al. Antimicrobial Agents and Chemotherapy . 2002
[7]
Antibiotic susceptibility of bacterial strains isolated from patients with various infections. Lee S H,Jeong S H. Letters in Applied Microbiology . 2002
[8]
Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. Canton R,Oliver A,Coque T M,et al. Journal of Clinical Microbiology . 2002
[9]
Clinical Isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China. Wang H,Kelkar S,Wu W,et al. Antimicrobial Agents and Chemotherapy . 2003
[10]
Surveillance of methicillin-resistant Staphylococcus aureus ( MRSA ) and Enterobacteriaceae producing extended-spectrum beta-lactamase ( ESBLE) in Northern France: a five-year multicentre incidence study. Albertini M T,Benoit C,Berardi L,et al. Journal of Hospital Infection . 2002